RxDoctor Payments Data

John Campana, MD

Plastic Surgery within the Head & Neck · Highlands Ranch, CONPI 1740373190

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,240 of the $3,198 with a category attached, or 70.1%. Axogen accounts for 62.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $1,454 and has fallen 68.7% since, to $455 in 2025.

$3,198in general payments, 2019–2025

Across 20 payments — averaging $159.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$2K
  • Medtronic$536
  • Stryker$168
  • Kls-martin L.p.$125
  • Johnson & Johnson$124
  • Sanofi$121
  • plus $137 from 5 others
$630in research payments, 2019–2025

Across 1 payment — averaging $629.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$630

What the payments were for

  • Travel & lodging$95830%
  • Food & beverage$2,24070%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,198 in reported general payments places this provider in the 75th percentile of 23 plastic surgery within the head & neck providers in Colorado.

See all plastic surgery within the head & neck providers in Colorado

Medicare billing

Part B allowed, 2024
$132,655
Medicare patients
169
Services billed
470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline36$1,482
Oxycodone Hcl23$126
Chlorhexidine Gluconate22$91

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Highlands Ranch

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →